Study finds omega-3 and omega-6 fatty acids have opposite effects on aging muscle in mice
A bioRxiv preprint study found that dietary supplementation with omega-3 (DHA) and omega-6 (ARA) fatty acids produced divergent effects on skeletal muscle in aging mice. DHA reduced chronic inflammation and restored a key regenerative marker, while ARA paradoxically worsened muscle strength and increased inflammatory markers despite improving body composition. The findings suggest that the ratio and type of polyunsaturated fatty acids may be important for maintaining muscle health during aging.
Researchers supplemented aging mice with either arachidonic acid (ARA, omega-6) or docosahexaenoic acid (DHA, omega-3) for 12 weeks to test their effects on sarcopenia—age-related muscle decline linked to chronic inflammation. While ARA reduced body fat and increased lean mass percentage, it unexpectedly decreased absolute muscle strength and myofiber size, accompanied by increased inflammation markers and reduced protein synthesis machinery. DHA, by contrast, reduced chronic muscle inflammation and restored c-Myc expression (a marker of regenerative capacity) to young levels, though it did not increase muscle mass or strength. The study suggests these two fatty acids, both precursors to inflammation-regulating molecules, have fundamentally different impacts on aging muscle structure and function, challenging the traditional view of ARA as uniformly pro-inflammatory.
Limitations & open questions
The study was conducted only in mice; human applicability remains unknown. The mechanisms by which ARA worsened muscle outcomes despite improving body composition are not fully explained. Long-term safety and optimal dosing for human supplementation are not addressed. The study does not compare these interventions to other established anti-sarcopenia approaches such as resistance exercise or other dietary interventions.
What different sources said
- bioRxivCenter
Dietary omega-6 arachidonic acid and omega-3 docosahexaenoic acid supplementation differentially impact skeletal muscle inflammaging in mice
Related
Study reveals IDH1 enzyme's role in cardiac metabolic adaptation during cancer-related stress
Researchers discovered that isocitrate dehydrogenase 1 (IDH1) helps the heart adapt to metabolic stress caused by cancer-related mutations through a previously unknown reductive metabolic pathway. The study used stable isotope tracing and genetic knockout models in rat and mouse heart tissue to show that when mitochondrial metabolism is impaired, IDH1 redirects carbon flux toward glutamine-derived citrate formation. This finding expands understanding of how cardiac metabolism responds to oncometabolic stress and may have implications for managing cardiovascular complications in cancer patients.
AI Framework Reveals How β-Arrestin 1 Protein Changes Shape During Activation
Researchers used a transformer-based artificial intelligence model to analyze how the β-arrestin 1 protein's tail region reorganizes when activated by cell surface receptors. The study examined molecular dynamics simulations comparing the protein in resting and active states, uncovering previously unknown conformational changes. This work could improve understanding of how cells regulate signaling pathways involved in numerous physiological and disease processes.
Study Links Pancreatic Cancer Tissue Stiffness to Tumor Progression and Patient Survival
Researchers combined imaging scans and laboratory tissue analysis to show that pancreatic cancer tumors with greater stiffness—driven by dense collagen buildup—correlate with worse patient survival outcomes. The study of nine patients found that magnetic resonance elastography, a non-invasive imaging technique, can detect mechanical properties that reflect underlying tumor biology. These findings suggest that measuring tissue stiffness through imaging could help doctors better characterize pancreatic cancer and guide treatment decisions.